Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T18:54:14.142Z Has data issue: false hasContentIssue false
  • English
  • Français

Pemoline induced Chorea and Gilles de la Tourette's Syndrome

Published online by Cambridge University Press:  29 January 2018

Chandra Mohan Bonthala ,
Albert West ,
Chandra Mohan Bonthala  and
Albert West
Albert West
Affiliation:
Duston, Northampton NN5 6UN
Get access Rights & Permissions [Opens in a new window]

Extract

Pemoline is a central nervous system stimulant, with pharmacological effects resembling amphetamine and methylphenidate in increasing central dopamine transmission (Fuxe et al, 1970; Sheel-Kurge, 1971).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 143 , Issue 3 , September 1983 , pp. 300 - 302
Copyright
Copyright © 1983 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Batchman, D. S. (1981) Pemoline induced Tourette disorder. American Journal of Psychiatry, 138, 1116–76.Google Scholar
Boris, M. (1968) Gilles de la Tourette syndrome: remission with Haloperidol. Journal of American Medical Association, 205, 648–9.Google Scholar
Clow, A., Jenner, P. & Marsden, C. D. (1979) Changes in dopamine mediated behaviour during one year's neuroleptic administration. European Journal of Pharmacology, 57, 365–75.CrossRefGoogle ScholarPubMed
Costall, B. & Naylor, R. J. (1972) Modification of amphetamine effects by intracerebrally administered anticholinergic agents. Life Science (I), 11, 239–53.Google ScholarPubMed
Crow, T. J. (1980) Drug treatment of schizophrenia and its relationship to disturbances of dopaminergic transmission. In Biochemistry of Psychiatric Disturbances (ed. Curzon, G.). Chichester: John Wiley.Google Scholar
Dawbarn, D. & Pycock, C. (1981) Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine. European Journal of Pharmacology, 71, 233–45.Google Scholar
Dren, T. A. & Janicki, R. S. (1978) Pemoline. In Pharmacological and Biochemical Properties of Drug Substances (ed. Morton, E. Goldberg). American Pharmaceutical Association.Google Scholar
Enoch, D. M. & Trethowan, W. H. (1979) Gilles de la Tourette's syndrome. In Uncommon Psychiatric Syndromes 2nd Edition. Bristol: John Wright.Google Scholar
Fernando, S. J. M. (1976) Six cases of Gilles de la Tourette's syndrome. British Journal of Psychiatry, 128, 436–41.CrossRefGoogle ScholarPubMed
Ferris, R. M., Tang, F. L. M. & Maxwell, R. A. (1972) A comparison of the capacities of the isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritrated catecholamines into rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. Journal of Pharmacology and Experimental Therapeutics, 181, 407–16.Google Scholar
Fuxe, K. & Ungerstedt, U. (1970) Histological, biochemical and functional studies on central mono amine neurones after acute and chronic amphetamine administration. In International Symposium on Amphetamine and Related Compounds (eds. Costa, E. and Grattini, ), 257–88. New York: Raven Press.Google Scholar
Golden, G. S. (1974) Gilles de la Tourette's syndrome following methylphenidate administration. Developmental Medical Child Neurology, 16, 76–8.Google Scholar
Harris, J. E. & Baldessarini, R. J. (1973) Uptake of 3H-catacholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues. Neuropharmacology, 12, 669–79.CrossRefGoogle ScholarPubMed
Jenner, P., Murugaiah, K., Mann, S., Theodorou, A. & Marsden, C. D. (1981) Continuous administration of cis-flupenthixol to rats for 14 months produced cerebral dopamine receptor supersensitivity and increases striatal acetylcholine levels. Abstract from III world congress of biological psychiatry, Stockholm 1981.Google Scholar
Mitchell, E. & Matthews, K. L. (1980) Gilles de la Tourette's syndrome associated with pemoline. American Journal of Psychiatry, 137, 1618–19.Google ScholarPubMed
Moller-Nielsen, I., Fjalland, B., Pedersen, V. & Nymberk, M. (1974) Pharmacology of neuroleptics upon related administration. Pharmacologia (Berlin), 34, 95.Google Scholar
Muller, J. & Aminoff, J. M. (1982) Tourette-like syndrome after long-term neuroleptic drug treatment. British Journal of Psychiatry, 141, 191–3.Google Scholar
Nausieda, P. A., Koller, W. C., Weiner, W. J. & Klawans, H. L. (1981) Pemoline induced chorea Neurology (NY), 31, 356–60.Google Scholar
Scatton, B. (1977) Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. European Journal of Pharmacology, 46, 363–9.CrossRefGoogle ScholarPubMed
Shapiro, A. K. & Shapiro, E. (1968) Treatment of Gilles de la Tourette's syndrome with haloperidol. British Journal of Psychiatry, 114, 345–50.CrossRefGoogle ScholarPubMed
Shapiro, A. K. & Shapiro, E. (1971) Clinical dangers of psychological theorizing. The Gilles de la Tourette's syndrome. Psychiatric Quarterly, 45, 159–71.Google Scholar
Shapiro, A. K., Shapiro, E., Wayne, J. & Clarion, D. (1973) Organic factors in Gilles de la Tourette's Syndrome. British Journal of Psychiatry, 122, 659–64.Google Scholar
Sheel-Kurge, J. (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catacholamines in the brain. European Journal of Pharmacology, 14, 47–59.Google Scholar
Singer, K. (1963) Gilles de la Tourette's disease. American Journal of Psychiatry, 120, 80–1.Google Scholar
Sweet, R. D., Soloman, S. E., Wayne, H., Shapiro, E. & Shapiro, A. K. (1973) Neurological features of Gilles de la Tourette's syndrome. Journal of Neurology, Neurosurgery and Psychiatry, 36, 1–9.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.